Key result
Acute ischemic stroke registry shows universal citicoline use, frequent statin therapy, and ~27% thrombolysis rates.
Why the study?
Acute ischemic stroke is associated with vascular, metabolic, and lifestyle-related risk factors, and its management involves multiple medication classes, warranting description of risk-factor profiles and drug utilisation among hospitalized patients.
Observational (n=120)
No
This descriptive study highlights a high burden of cardiovascular comorbidities (particularly hypertension with atrial fibrillation or CAD) and universal use of neuroprotective and gastroprotective agents alongside standard antithrombotic and statin therapies in an Indian acute ischemic stroke cohort.
Answers are grounded in this paper and cite their sources.
Supports comorbidity screening in acute stroke; extends real-world antiplatelet patterns but remains hypothesis-generating.
Background: Acute ischemic stroke (AIS) is associated with vascular, metabolic, and lifestyle-related risk factors, and its management involves several medication classes. Objective: To describe risk-factor profiles and drug utilisation among hospitalized patients with AIS. Methods: A six-month prospective observational study included 120 adults with computed tomography or magnetic resonance imaging-confirmed AIS at KIMS Hospital, Secunderabad. Demographic, comorbidity, social-history, and medication data were collected using structured forms and summarized with IBM SPSS version 24. Results: Mean age was 59.75 ± 13.8 years. The largest age group was 41–50 years (31 patients; 25.83%), and the results tables recorded 81 males (67.5%) and 39 females (32.5%). Hypertension with atrial fibrillation was the most frequent recorded comorbidity category (23; 19.17%), followed by hypertension with coronary artery disease (22; 18.33%). Alcohol use was recorded in 36 patients (30%), smoking in 30 (25%), and both in 20 (16.67%). Citicoline and pantoprazole were each prescribed to all 120 patients. Aspirin, clopidogrel, and aspirin-plus-clopidogrel were recorded in 50, 46, and 49 patients, respectively; atorvastatin and rosuvastatin in 63 and 57. Thrombolysis was recorded in 32 patients (26.6%). Conclusion: The cohort had substantial cardiovascular comorbidity and frequent exposure to antithrombotic, lipid-lowering, and supportive medicines. The findings describe local prescribing and risk profiles; patient-level assessment is needed to determine treatment appropriateness, safety, and clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Usha et al. (2026) conducted an observational in Acute ischemic stroke (n=120). Drug utilisation and risk-factor profiles was evaluated on Risk-factor profiles and drug utilisation patterns. Drug utilisation in 120 acute ischemic stroke patients included 100% citicoline and pantoprazole use, 26.6% thrombolysis, and frequent antiplatelet and statin therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: